Evaluating the effectiveness of mandibular advancement devices in treating very severe obstructive sleep apnea: a retrospective cohort study
Sleep and Breathing · 2025
DOI: 10.1007/s11325-025-03249-8 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Sleep and Breathing, 2025. Verfasst von Shirley Leibovitz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Dentistry, Barzilai Medical Center, Ashkelon, Israel. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Mandibular Advancement. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The repeated airway obstructions in the common disorder Obstructive Sleep Apnea (OSA) cause health risks. Continuous Positive Airway Pressure (CPAP), the standard treatment, faces adherence challenges. Mandibular Advancement Devices (MADs) have been used successfully for mild to moderate OSA, as a good alternative for these patients. OBJECTIVE: to evaluate the effectiveness of MADs in reducing the Apnea-Hypopnea Index (AHI) and improving symptoms in patients with very severe OSA unable to tolerate CPAP. METHODS: This retrospective study included 22 patients with very severe OSA (AHI ≥ 50) treated with MADs. Baseline characteristics, including: age, sex, BMI, and AHI, were recorded, and changes in AHI following treatment were assessed. Adherence was monitored using patient-reported data. Unlike previous studies, this research focuses exclusively on the efficacy of MADs in treating patients with very severe OSA, a population often excluded from similar inspections. RESULTS: median AHI significantly decreased from 60.0 (IQR: 57.0-65.0) to 15.0 (IQR: 10.0-24.0) after treatment (P < 0.001), with a mean reduction of 72.5% (± 14.3). Notably, 95.5% of patients achieved at least a 50% reduction in AHI. Symptom improvements, including reduced snoring and daytime tiredness, were reported by 72.7% of patients. BMI positively correlated with baseline AHI, and significant AHI reductions were observed across overweight and obese categories, although some patients remained in the severe AHI range post-treatment. Adherence varied, with 63.6% continuing to use the device. CONCLUSIONS: MADs are effective in managing very severe OSA, providing significant reductions in AHI and symptom improvements. MADs may be a viable alternative for patients unable to tolerate CPAP. Further investigations into the long-term efficacy and impact on quality of life are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Dentistry, Barzilai Medical Center, Ashkelon, Israel.
- The Institute of Biomedical and Oral Research, Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
- Department of Oral Medicine, Sedation and Imaging, Hadassah Medical Center, Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
- Department of Oral Medicine, Sedation and Imaging, Hadassah Medical Center, Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. yaronha@hadassah.org.il.
- Department of Oral Medicine, Hebrew University- Hadassah School of Dental Medicine, PO Box 91120, Jerusalem, Israel. yaronha@hadassah.org.il.
ORCID-Profile: Yaron Haviv
Zitieren
APA
Leibovitz, S., Levi, S., Hanut, A., Yanko, R., Sharav, Y., & Haviv, Y. (2025). Evaluating the effectiveness of mandibular advancement devices in treating very severe obstructive sleep apnea: a retrospective cohort study. Sleep and Breathing. https://doi.org/10.1007/s11325-025-03249-8
Vancouver
Leibovitz S, Levi S, Hanut A, Yanko R, Sharav Y, Haviv Y. Evaluating the effectiveness of mandibular advancement devices in treating very severe obstructive sleep apnea: a retrospective cohort study. Sleep and Breathing. 2025. doi:10.1007/s11325-025-03249-8
BibTeX
@article{Leibovitz2025,
author = {Leibovitz, Shirley and Levi, Shai and Hanut, Aiham and Yanko, Robert and Sharav, Yair and Haviv, Yaron},
title = {Evaluating the effectiveness of mandibular advancement devices in treating very severe obstructive sleep apnea: a retrospective cohort study},
journal = {Sleep and Breathing},
year = {2025},
doi = {10.1007/s11325-025-03249-8}
}
EUVIMED